Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Loss of function of the new interferon IFN-λ4 may confer protection from hepatitis C

Nature Genetics volume 45, pages 119–120 (2013)Cite this article

Subjects

Attempts to elucidate the mechanism underpinning the genetic association between IFNL3, previously called IL28B, and clearance of hepatitis C virus have, by and large, been unsuccessful. A study in this issue suggests that a new gene, IFNL4, may be responsible.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: IFNL4 genomic location and signaling.

References

  1. Ge, D. et al. Nature 461, 399–401 (2009).

    Article  CAS  Google Scholar 

  2. Suppiah, V. et al. Nat. Genet. 41, 1100–1104 (2009).

    Article  CAS  Google Scholar 

  3. Tanaka, Y. et al. Nat. Genet. 41, 1105–1109 (2009).

    Article  CAS  Google Scholar 

  4. Rauch, A. et al. Gastroenterology 138, 1338–1345 (2010).

    Article  CAS  Google Scholar 

  5. Prokunina-Olsson, L. et al. Nat. Genet. 45, 164–171 (2013).

    Article  CAS  Google Scholar 

  6. Urban, T.J. et al. Hepatology 52, 1888–1896 (2010).

    Article  CAS  Google Scholar 

  7. Dill, M.T. et al. Gastroenterology 140, 1021–1031 (2011).

    Article  CAS  Google Scholar 

  8. Honda, M. et al. Gastroenterology 139, 499–509 (2010).

    Article  CAS  Google Scholar 

  9. Naggie, S. et al. Hepatology 56, 444–454 (2012).

    Article  CAS  Google Scholar 

  10. Smith, K.R. et al. Genome Med. 3, 57 (2011).

    Article  CAS  Google Scholar 

  11. Poordad, F. et al. Hepatology 54, Suppl. 1 (2011).

  12. Jacobson, I.M. et al. J. Hepatol. 54, Suppl. 1 (2011).

  13. Zeuzem, S. et al. J. Hepatol. 56, Suppl. 2 (2012).

  14. Chu, T.W. et al. Gastroenterology 142, 790–795 (2012).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. David Booth is at the Institute for Immunology and Allergy Research, Westmead Millennium Institute, University of Sydney, Sydney, New South Wales, Australia.,

    David Booth

  2. Jacob George is at the Storr Liver Unit, Westmead Millennium Institute and Westmead Hospital, University of Sydney, Sydney, New South Wales, Australia.,

    Jacob George

Authors
  1. David Booth
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jacob George
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jacob George.

Ethics declarations

Competing interests

D.B. and J.G. have filed patent applications in Australia and the United States for use of the IL28B gene region to predict drug response.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Booth, D., George, J. Loss of function of the new interferon IFN-λ4 may confer protection from hepatitis C. Nat Genet 45, 119–120 (2013). https://doi.org/10.1038/ng.2537

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng.2537

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing